Manufacturer's investigation conclusion: the report of a non-occlusive thrombus in the outflow graft could not be confirmed through this evaluation.It was reported that there was an incidental finding of a possible non-occlusive thrombus in the outflow graft through a computed tomography angiography (cta) scan.The submitted log file contained approximately 11 days of data.No hazard alarms were observed within the file.The pump remained above the low speed limit for the duration of the file.The pump appeared to be functioning as intended.The account later communicated that the thrombus could not be confirmed.The patient remains ongoing on heartmate ii left ventricular assist system (lvas), serial number (b)(6).No further related events have been reported at this time.The heartmate ii left ventricular assist system (lvas) instructions for use (ifu), is currently available.Section 1 of this ifu lists device thrombosis as an adverse event that may be associated with the use of the heartmate ii left ventricular assist system.This ifu outlines indications of pump thrombosis as well as how to respond to such events.Section 6 also outlines the suggested anticoagulation regimen and international normalized ratio (inr) range that should be maintained for patients using the heartmate ii lvas.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped on 04feb2013.No further information was provided.The manufacturer is closing the file on this event.
|